EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC 4.0

Venous thromboembolism incidence associated with pegylated asparaginase (ASP) compared to the native L‐ASP: A retrospective analysis with an ASP‐based protocol in adult patients with acute lymphoblastic leukaemia

RuiQi Chen iD, Eshetu G Atenafu iD, Jack Seki, Xing Liu, Steven Chan, Vikas Gupta iD, Dawn Maze iD, Andre C Shuh, Mark D Minden, Karen Yee, Aaron D Schimmer, Hassan Sibai iD

British Journal of Haematology · 2023

DOI: 10.1111/bjh.18683 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift British Journal of Haematology, 2023. Verfasst von RuiQi Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Venous Thromboembolism, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Venous thromboembolism (VTE) is a well‐known complication in patients with acute lymphoblastic leukaemia (ALL) receiving asparaginase (ASP)‐based chemotherapy, including the ASP‐intensive Dana‐Farber Cancer Institute (DFCI) 91–01 protocol for adults. Since 2019, native L‐ASP is no longer available in Canada and was replaced by pegylated (PEG)‐ASP. To determine whether the incidence of VTE has changed since switching from L‐ASP to PEG‐ASP, we conducted a single‐centred retrospective cohort study. We included 245 adult patients with Philadelphia chromosome negative ALL between 2011 and 2021, with 175 from the L‐ASP group (2011–2019) and 70 from the PEG‐ASP group (2018–2021). During Induction, 10.29% (18/175) of patients who received L‐ASP developed VTE, whereas 28.57% (20/70) of patients who received PEG‐ASP developed VTE ( p = 0.0035; odds ratio [OR] 3.35, 95% confidence interval [CI] 1.51–7.39), after adjusting for line type, gender, history of VTE, platelets at diagnosis. Similarly, during Intensification, 13.64% (18/132) of patients had VTE on L‐ASP while 34.37% (11/32) of patients on PEG‐ASP developed VTE ( p = 0.0096; OR 3.96, 95% CI 1.57–9.96 with multivariable analysis). We found that PEG‐ASP is associated with a higher incidence of VTE compared to L‐ASP, both during Induction and Intensification, despite the administration of prophylactic anticoagulation. Further VTE mitigation strategies are needed in particular for adult patients with ALL receiving PEG‐ASP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismPrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic AgentsHumansAdultAsparaginaseRetrospective StudiesIncidencePolyethylene Glycols

Stichwörter der Autor:innen

DFCI 91-01 protocolacute lymphoblastic leukemiaasparaginasetherapy-related thrombosis

Substanzen

pegaspargaseAsparaginasePolyethylene GlycolsAntineoplastic Agents

Autor:innen und Institutionen

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada.

ORCID-Profile: RuiQi Chen, Eshetu G Atenafu, Vikas Gupta, Dawn Maze, Hassan Sibai

Zitieren

APA

Chen, R., Atenafu, E. G., Seki, J., Liu, X., Chan, S., Gupta, V., Maze, D., Shuh, A. C., Minden, M. D., Yee, K., Schimmer, A. D., & Sibai, H. (2023). Venous thromboembolism incidence associated with pegylated asparaginase (ASP) compared to the native L‐ASP: A retrospective analysis with an ASP‐based protocol in adult patients with acute lymphoblastic leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.18683

Vancouver

Chen R, Atenafu EG, Seki J, Liu X, Chan S, Gupta V, et al. Venous thromboembolism incidence associated with pegylated asparaginase (ASP) compared to the native L‐ASP: A retrospective analysis with an ASP‐based protocol in adult patients with acute lymphoblastic leukaemia. British Journal of Haematology. 2023. doi:10.1111/bjh.18683

BibTeX
@article{Chen2023,
  author = {Chen, RuiQi and Atenafu, Eshetu G and Seki, Jack and Liu, Xing and Chan, Steven and Gupta, Vikas and Maze, Dawn and Shuh, Andre C and Minden, Mark D and Yee, Karen and Schimmer, Aaron D and Sibai, Hassan},
  title = {Venous thromboembolism incidence associated with pegylated asparaginase (ASP) compared to the native L‐ASP: A retrospective analysis with an ASP‐based protocol in adult patients with acute lymphoblastic leukaemia},
  journal = {British Journal of Haematology},
  year = {2023},
  doi = {10.1111/bjh.18683}
}
Kostenlos starten →